Atlas Trials

Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients

Clinical trial NCT03145480 · TERMINATED

Trial details

NCT number
NCT03145480
Sponsor
Northwell Health
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Richter Syndrome
Start date
2017-06-19
Primary completion
2018-09-28
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.